AIM: To investigate the possible relationships between gastric autoimmune phenomena and clinical presentations of this disorder, in consecutive atrophic body gastritis patients. METHODS: A total of 140 atrophic body gastritis patients, diagnosed as consecutive outpatients presenting with macrocytic or iron deficiency anemia, or longstanding dyspepsia underwent gastroscopy with antral and body biopsies, assay of intrinsic factor, parietal cells and Helicobacter pylori (H pylori) antibodies. Gastritis was assessed according to Sydney System. RESULTS: Parietal cell antibodies were equally distributed in all clinical presentations, whereas the positivity of intrinsic factor antibodies (49/140, 35%) was significantly higher in pernicious anemia patients (49.2%) than in iron deficiency (21.1%) and dyspeptic patients (27.8%). No specific pattern of autoantibodies was related to the clinical presentations of atrophic body gastritis. A positive correlation was obtained between the body atrophy score and the intrinsic factor antibody levels (r = 0.2216, P = 0.0085). Associated autoimmune diseases were present in 25/140 (17.9%) patients, but the prevalence of autoimmune diseases was comparable, irrespective of the clinical presentations. CONCLUSION: The so-called hallmarks of gastric autoimmunity, particularly in intrinsic factor antibody cannot be usefully employed in defining an autoimmune pattern in the clinical presentations of ABG.
AIM: To investigate the possible relationships between gastric autoimmune phenomena and clinical presentations of this disorder, in consecutive atrophic body gastritispatients. METHODS: A total of 140 atrophic body gastritispatients, diagnosed as consecutive outpatients presenting with macrocytic or iron deficiency anemia, or longstanding dyspepsia underwent gastroscopy with antral and body biopsies, assay of intrinsic factor, parietal cells and Helicobacter pylori (H pylori) antibodies. Gastritis was assessed according to Sydney System. RESULTS: Parietal cell antibodies were equally distributed in all clinical presentations, whereas the positivity of intrinsic factor antibodies (49/140, 35%) was significantly higher in pernicious anemiapatients (49.2%) than in iron deficiency (21.1%) and dyspeptic patients (27.8%). No specific pattern of autoantibodies was related to the clinical presentations of atrophic body gastritis. A positive correlation was obtained between the body atrophy score and the intrinsic factor antibody levels (r = 0.2216, P = 0.0085). Associated autoimmune diseases were present in 25/140 (17.9%) patients, but the prevalence of autoimmune diseases was comparable, irrespective of the clinical presentations. CONCLUSION: The so-called hallmarks of gastric autoimmunity, particularly in intrinsic factor antibody cannot be usefully employed in defining an autoimmune pattern in the clinical presentations of ABG.
Authors: R Negrini; I Zanella; A Savio; C Poiesi; R Verardi; S Ghielmi; A Albertini; O Sangaletti; M Lazzaroni; G Bianchi Porro Journal: Scand J Gastroenterol Date: 1992-07 Impact factor: 2.423
Authors: G Delle Fave; A Kohn; L De Magistris; B Annibale; R Bruzzone; C Sparvoli; C Severi; A Torsoli Journal: Gut Date: 1983-03 Impact factor: 23.059
Authors: B Annibale; E Lahner; C Bordi; G Martino; P Caruana; C Grossi; R Negrini; G Delle Fave Journal: Dig Liver Dis Date: 2000-12 Impact factor: 4.088
Authors: E Lahner; C Bordi; E Di Giulio; P Caruana; G D'Ambra; M Milione; C Grossi; G Delle Fave; B Annibale Journal: Aliment Pharmacol Ther Date: 2002-03 Impact factor: 8.171
Authors: B Annibale; L De Magistris; V Corleto; G D'Ambra; M Marignani; C Iannoni; G Delle Fave Journal: Aliment Pharmacol Ther Date: 1994-02 Impact factor: 8.171
Authors: Amedeo Amedei; Mathijs P Bergman; Ben J Appelmelk; Annalisa Azzurri; Marisa Benagiano; Carlo Tamburini; Ruurd van der Zee; John L Telford; Christina M J E Vandenbroucke-Grauls; Mario M D'Elios; Gianfranco Del Prete Journal: J Exp Med Date: 2003-10-20 Impact factor: 14.307